RxDoctor Payments Data

Alan Feldman, MD

Psychiatry · Largo, FLNPI 1922108968

Payments from drug & device makers

$501in general payments, 2019–2025

Across 30 payments — averaging $16.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$207
  • Sunovion Pharmaceuticals Inc.$88
  • AbbVie$80
  • Sumitomo Pharma America, Inc.$28
  • Eisai Inc.$24
  • Supernus Pharmaceuticals, Inc.$21
  • plus $54 from 3 others

What the payments were for

  • Food & beverage$501100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$501 in reported general payments places this provider in the 50th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$161,257
Medicare patients
361
Services billed
2,409

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl107$152,114
Invega SustennaPaliperidone Palmitate29$115,701
Abilify MaintenaAripiprazole18$44,376
Risperdal ConstaRisperidone Microspheres15$37,664
Aripiprazole458$24,178
CaplytaLumateperone Tosylate12$22,738
LybalviOlanzapine/Samidorphan Malate14$21,288
Olanzapine522$20,003
RexultiBrexpiprazole12$17,253
TrintellixVortioxetine Hydrobromide12$16,024
Quetiapine Fumarate793$15,530
Duloxetine Hcl570$13,149
Ziprasidone Hcl181$12,194
Lurasidone Hcl67$9,663
Trazodone Hcl991$9,536

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$80$152,114107 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$207$61,62830 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Largo

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →